My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2015
POLICY AND ADVOCACY
Progress on the Road to 10 x 20

IDSA members can support IDSA’s goal of having 10 new antibiotics by 2020 by taking three minutes to sign the latest Action Alert urging the Senate to pass the recently reintroduced PATH Act. PATH, or Promise for Antibiotics and Therapeutics for Health, would establish a new limited population antibacterial drug approval pathway for antibacterial drugs to treat serious or life-threatening infections where there exists an unmet medical need. This important legislation was recently reintroduced in the Senate by Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO).

More good news on the antibiotic front was announced late last year with the approval of ceftolozane/tazobactam from Cubist Pharmaceuticals. This is the fifth antibiotic approved since the launch of the 10 x ’20 initiative in 2010.

Although IDSA applauded the new drug’s approval, the Society’s press statement pointed out that patients still face life-threatening infections for which additional new antibiotics are urgently needed. The PATH Act would help by reducing regulatory burdens to new drug development.




< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
New Resources Available for Accessing Guidelines
Sanford Guide Mobile App for Lab Diagnosis of Infectious Diseases
CDC Investigates U.S. Multi-State Measles Outbreak
CLINICAL PRACTICE MANAGEMENT
New HIVMA Website Offers Resources for HIV Medical Providers and Clinics
CMS Publishes Final Rule for Physician Fee Schedule
POLICY AND ADVOCACY
Obama Requests Doubling of Funds to Combat Antibiotic Resistance
New Report, The Promise of Next Generation Diagnostics, Targets Policymakers
Progress on the Road to 10 x 20
FDA Moves to Replace Lifetime MSM Blood Donation Ban with One-Year Deferral
GLOBAL ID
Science Speaks: Neglecting ID Anywhere Poses a Threat Everywhere
YOU AND YOUR COLLEAGUES
Members on the Move
New Members
TOP STORIES
From the President
IDWeek 2015 Sneak Preview of Keynote Speakers
IDSA Foundation Offers Research Awards to Young Investigators
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.